Evaluation of the effectiveness of the 13-valent pneumococcal conjugate vaccine on pneumococcal serotypes causing pneumonia in children [ 2014 - 2018 ]

Also known as: Impact of pneumococcal vaccine on childhood pneumonia

Research Grant

[Cite as]

Researchers: Prof Adam Jaffe (Principal investigator) ,  A/Pr Stephen Lambert A/Pr Thomas Snelling Dr Melanie Wong Prof Gwendolyn Gilbert

Brief description Streptococcus pneumonia (Pneumococcus) is a bug that is a leading cause of childhood morbidity and mortality world-wide. Vaccinations have been recently brought onto the national immunisation program to try and combat this. This study aims to assess the new 13 valent Pneumococcal vaccine by studying its effectiveness in preventing childhood pneumonia in Australia by analysing the strains of Pneumococus in the blood and the fluid surrounding the lining the lung in complicated pneumonia using sensitive molecular techniques.

Funding Amount $AUD 1,137,532.65

Funding Scheme Project Grants

Notes Standard Project Grant

Click to explore relationships graph
Viewed: [[ro.stat.viewed]]